September 25, 2016 6:44 AM ET

Biotechnology

Company Overview of Koronis Pharma, Inc.

Company Overview

Koronis Pharma, Inc. develops antiviral therapeutics based on Viral Decay Acceleration mechanism. It develops KP-1461 for the treatment of HIV virus; and products for the treatment of antiviral infections. The company was founded in 1998 and is based in Seattle, Washington.

500 Union Street

Suite 835

Seattle, WA 98101

United States

Founded in 1998

Phone:

206-682-1181

Fax:

206-682-8077

Key Executives for Koronis Pharma, Inc.

Consulting Chief Medical Director and Clinical & Scientific Advisor
Member of Clinical Advisory Board and Clinical and Scientific Advisor
Member of Clinical Advisory Board and Clinical & Scientific Advisor
Clinical and Scientific Advisor
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Koronis Pharma, Inc., please visit www.koronispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.